Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 639868, 6 pages
http://dx.doi.org/10.1155/2014/639868
Research Article

Effect of the French Oak Wood Extract Robuvit on Markers of Oxidative Stress and Activity of Antioxidant Enzymes in Healthy Volunteers: A Pilot Study

1Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Sasinkova 2, 811 08 Bratislava, Slovakia
2Institute of Medical Biochemistry, Jessenius Faculty of Medicine, Comenius University, Malá Hora 4, 036 01 Martin, Slovakia
32nd Department of Internal Medicine, Faculty of Medicine, Comenius University, Mickiewiczova 13, 813 69 Bratislava, Slovakia
4Westfälische Wilhelms-Universität Münster, Institut für Pharmazeutische Chemie, Twenteweg 15, 48161 Münster, Germany

Received 18 June 2014; Accepted 8 August 2014; Published 31 August 2014

Academic Editor: Cristina Angeloni

Copyright © 2014 Martina Horvathova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Mayer, W. Gabler, A. Riester, and H. Korger, “On tannins compounds from the wood of chestnut and oak wood-IIs. Isolation of castalagin, vescalagin, castalin and vescaline,” Liebigs Annual of Chemistry, vol. 707, pp. 177–181, 1967. View at Google Scholar
  2. C. L. M. H. du Penhoat, V. M. F. Michon, S. Peng, C. Viriot, A. Scalbert, and D. Gage, “Structural elucidation of new dimeric ellagitannins from Quercus robur,” Journal of the Chemical Society, no. 7, pp. 1653–1660, 1991. View at Google Scholar · View at Scopus
  3. F. Natella, G. Leoni, M. Maldini et al., “Absorption, metabolism, and effects at transcriptome level of a standardized French oak wood extract, Robuvit , in healthy volunteers: pilot study,” Journal of Agricultural and Food Chemistry, vol. 62, no. 2, pp. 443–453, 2014. View at Google Scholar
  4. A. Glabasnia and T. Hofmann, “Sensory-directed identification of taste-active ellagitannins in American (Quercus alba L.) and European oak wood (Quercus robur L.) and quantitative analysis in bourbon whiskey and oak-matured red wines,” Journal of Agricultural and Food Chemistry, vol. 54, no. 9, pp. 3380–3390, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. N. P. Seeram, S. M. Henning, Y. Zhang, M. Suchard, Z. Li, and D. Heber, “Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours,” The Journal of Nutrition, vol. 136, no. 10, pp. 2481–2485, 2006. View at Google Scholar · View at Scopus
  6. G. Celik, A. Semiz, S. Karakurt, S. Arslan, O. Adali, and A. Sen, “A comparative study for the evaluation of two doses of ellagic acid on hepatic drug metabolizing and antioxidant enzymes in the rat,” BioMed Research International, vol. 2013, Article ID 358945, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Kavitha, P. Thiyagarajan, J. Rathna, R. Mishra, and S. Nagini, “Chemopreventive effects of diverse dietary phytochemicals against DMBA-induced hamster buccal pouch carcinogenesis via the induction of Nrf2-mediated cytoprotective antioxidant, detoxification, and DNA repair enzymes,” Biochimie, vol. 95, no. 8, pp. 1629–1639, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. S. Kim, T. Zerin, and H. Y. Song, “Antioxidant action of ellagic acid ameliorates paraquat-induced A549 cytotoxicity,” Biological and Pharmaceutical Bulletin, vol. 36, no. 4, pp. 609–615, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Qiu, B. Zhou, L. Jin et al., “In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells,” Food and Chemical Toxicology, vol. 59, pp. 428–437, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Chung, L. Lu, M. Tsai, Y. Chen, S. Yao, and C. Hsu, “The inhibitory effect of ellagic acid on cell growth of ovarian carcinoma cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 306705, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Umesalma, P. Nagendraprabhu, and G. Sudhandiran, “Antiproliferative and apoptotic-inducing potential of ellagic acid against 1, 2-dimethyl hydrazine-induced colon tumorigenesis in Wistar rats,” Molecular and Cellular Biochemistry, vol. 388, no. 1-2, pp. 157–172, 2014. View at Publisher · View at Google Scholar
  12. L. Vanella, C. di Giacomo, R. Acquaviva et al., “Effects of ellagic acid on angiogenic factors in prostate cancer cells,” Cancers, vol. 5, no. 2, pp. 726–738, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Zhao, S. Tang, J. L. Marsh, S. Shankar, and R. K. Srivastava, “Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice,” Cancer Letters, vol. 337, no. 2, pp. 210–217, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. R. Loizzo, A. Said, R. Tundis et al., “Antioxidant and antiproliferative activity of Diospyros lotus L. extract and isolated compounds,” Plant Foods for Human Nutrition, vol. 64, no. 4, pp. 264–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Marín, R. M. Giner, J. L. Ríos, and M. C. Recio, “Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulphate sodium model of mice colitis,” Journal of Ethnopharmacology, vol. 150, no. 3, pp. 925–934, 2013. View at Google Scholar
  16. M. A. Rosillo, M. Sánchez-Hidalgo, A. Cárdeno et al., “Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats,” Pharmacological Research, vol. 66, no. 3, pp. 235–242, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Larrosa, F. A. Tomás-Barberán, and J. C. Espín, “The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway,” Journal of Nutritional Biochemistry, vol. 17, no. 9, pp. 611–625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Chang, W. Chen, K. Lin et al., “Novel bioactivity of ellagic acid in inhibiting human platelet activation,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 595128, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, and C. Rice-Evans, “Antioxidant activity applying an improved ABTS radical cation decolorization assay,” Free Radical Biology and Medicine, vol. 26, no. 9-10, pp. 1231–1237, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Witko-Sarsat, M. Friedlander, C. Capeillère-Blandin et al., “Advanced oxidation protein products as a novel marker of oxidative stress in uremia,” Kidney International, vol. 49, no. 5, pp. 1304–1313, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Buss, T. P. Chan, K. B. Sluis, N. M. Domigan, and C. C. Winterbourn, “Protein carbonyl measurement by a sensitive ELISA method,” Free Radical Biology and Medicine, vol. 23, no. 3, pp. 361–366, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Kalousová, J. Škrha, and T. Zíma, “Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus,” Physiological Research, vol. 51, pp. 597–604, 2002. View at Google Scholar
  23. A. R. Collins, V. L. Dobson, M. Dušinská, G. Kennedy, and R. Štětina, “The comet assay: what can it really tell us?” Mutation Research, vol. 375, no. 2, pp. 183–193, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. C. M. Gedik, A. Collins, and ESCODD, “Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study,” The FASEB Journal, vol. 19, no. 1, pp. 82–84, 2005. View at Google Scholar
  25. M. El-Saadani, H. Esterbauer, M. El-Sayed, M. Goher, A. Y. Nassar, and G. Jurgens, “A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent,” Journal of Lipid Research, vol. 30, no. 4, pp. 627–630, 1989. View at Google Scholar · View at Scopus
  26. H. U. Bergmeyer, Methods of Enzymatic Analysis, Volume III: Enzymes 1: Oxidoreductases, Transferases, Verlag Chemie, Weiheim, Germany, 1987.
  27. D. Huang, B. Ou, M. Hampsch-Woodill, J. A. Flanagan, and R. L. Prior, “High-throughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format,” Journal of Agricultural and Food Chemistry, vol. 50, no. 16, pp. 4437–4444, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay,” Analytical Biochemistry, vol. 239, no. 1, pp. 70–76, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. J. C. Espín, M. Larrosa, M. T. García-Conesa, and F. Tomás-Barberán, “Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far,” Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 270418, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus